Concomitant use of clopidogrel and proton pump inhibitors or cimetidine after acute myocardial infarction would increase the risk of re-infarction

American Journal of Gastroenterology

Volumn 104, Issue 12, 2009, Pages 3116-3117

  Sheng Wen Wang, Sophie ^a   Tsai, Shang Shyue ^b   Hsu, Po Chao ^a   Yang, Chun Yuh ^c   Wu, Deng Chyang ^a,c,d  

^a KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b I SHOU UNIVERSITY   (Taiwan)

^c KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^d NATIONAL SUN YAT SEN UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CIMETIDINE; CLOPIDOGREL; CYTOCHROME P450 2C19; PROTON PUMP INHIBITOR;

ACUTE CORONARY SYNDROME; ACUTE HEART INFARCTION; ALLELE; DRUG EFFICACY; HEART REINFARCTION; HIGH RISK PATIENT; HUMAN; LETTER; PRIORITY JOURNAL; RISK ASSESSMENT; TAIWAN;

ALLELES; ANTI-ULCER AGENTS; ARYL HYDROCARBON HYDROXYLASES; CIMETIDINE; DRUG INTERACTIONS; FEMALE; HUMANS; MALE; MYOCARDIAL INFARCTION; ODDS RATIO; PLATELET AGGREGATION INHIBITORS; PROTON PUMP INHIBITORS; TAIWAN; TICLOPIDINE;

EID: 72949084837     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2009.525     Document Type: Letter

References (5)

1. Ho PM, Maddox TM, Wang L et al. Risk of adverse outcomes associated with concomitant use of clopidogrel and proton pump inhibitors following acute coronary syndrome. JAMA 2009;301:937-944
2. Mega JL, Close SL, Wiviott SD et al. Cytochrome p-450 polymorphisms and response to clopidogrel. N Engl J Med 2009;360:354-362
3. Simon T, Verstuyft C, Mary-Krause M et al. Genetic determinants of response to clopidogrel and cardiovascular events. N Engl J Med 2009;360:363-375
4. Furuta T, Shirai N, Sugimoto M et al. Influence of CYP2C19 pharmacogenetic polymorphism on proton pump inhibitor-based therapies. Drug Metab Pharmacokinet 2005;20:153-167
5. Kuo CH, Hu HM, Kuo FC et al. Efficacy of levo-floxacin-based rescue therapy for Helicobacter pylori infection after standard triple therapy: a randomized controlled trial. J Antimicrob Chemother 2009;63:1017-1024